iBio, Inc.
IBIO
$0.85
$0.000.53%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 14.29% | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.29% | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 14.29% | -- | -- | -- | -- |
| SG&A Expenses | -11.05% | 9.22% | -7.40% | -21.03% | -6.32% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 50.61% | 34.56% | 2.74% | -20.32% | -27.81% |
| Operating Income | -52.48% | -34.56% | 1.71% | 19.54% | 31.34% |
| Income Before Tax | -59.06% | -84.48% | 2.76% | 21.38% | 34.18% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -59.06% | -84.48% | 2.76% | 21.38% | 34.18% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -311.63% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 33.62% | -53.25% | 46.85% | 30.58% | -28.92% |
| EBIT | -52.48% | -34.56% | 1.71% | 19.54% | 31.34% |
| EBITDA | -56.61% | -38.63% | 0.89% | 19.60% | 32.50% |
| EPS Basic | 60.41% | 42.30% | 89.20% | 90.37% | 87.11% |
| Normalized Basic EPS | 5.16% | 49.65% | 80.24% | 89.09% | 93.42% |
| EPS Diluted | 60.41% | 42.32% | 89.20% | 90.37% | 87.11% |
| Normalized Diluted EPS | 5.16% | 49.65% | 80.24% | 89.09% | 93.42% |
| Average Basic Shares Outstanding | 67.66% | 165.61% | 392.03% | 620.62% | 900.35% |
| Average Diluted Shares Outstanding | 67.66% | 165.61% | 392.03% | 620.62% | 900.35% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |